TO PRESENT AT COWEN & ROTH
And the winner is?
So far, MDVN up 6% today, vs PPHM stagnant
Might be interesting to compare the post-conference price action.
Where is our true valuation heading? And when do we dump Gendel?
Good luck,
NHwild
Medivation Announces Participation in Upcoming Conferences 8:00a ET March 1, 2010 (PR NewsWire)
Medivation, Inc. (Nasdaq: MDVN) today announced that David Hung, M.D., president and chief executive officer, will present at the following conferences:
The Cowen Healthcare Conference, Monday, March 8, at 4:45 p.m. Eastern Time at the Marriott Copley Place Hotel in Boston
The ROTH 22nd Annual OC Growth Stock Conference, on Tuesday, March 16, at 12:30 p.m. Pacific Time at the Ritz-Carlton in Dana Point, Calif.
Dr. Hung will provide an overview of Medivation and its clinical development programs including dimebon (latrepirdine) for Alzheimer's and Huntington diseases and MDV3100 for prostate cancer.
Peregrine Pharmaceuticals to Present at Two Upcoming Investor Conferences 8:00a ET March 1, 2010 (PR NewsWire)
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that senior management will present at the following upcoming investor conferences:
etc, BUT WHAT do they present about, eh?
Market Data 
Markets 
AI
